A pyrazine-derived DIPEPTIDYL-PEPTIDASE IV INHIBITOR and HYPOGLYCEMIC AGENT that increases the levels of the INCRETIN hormones GLUCAGON-LIKE PEPTIDE-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). It is used in the treatment of TYPE 2 DIABETES.
Sitagliptin — Januvia
Phosphate, Sitagliptin — Sitagliptin Phosphate Monohydrate — Monohydrate, Sitagliptin Phosphate — Phosphate Monohydrate, Sitagliptin — Sitagliptin Monophosphate Monohydrate — Monohydrate, Sitagliptin Monophosphate — Monophosphate Monohydrate, Sitagliptin — MK 0431 — 0431, MK — MK0431 — MK-0431 — Sitagliptin Phosphate Anhydrous — Anhydrous, Sitagliptin Phosphate — Phosphate Anhydrous, Sitagliptin — Sitagliptin — 4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine — Januvia